A Study to Assess the Absolute Bioavailability of a Single Oral Dose of Fostamatinib With Respect to an Intravenous Micro Tracer Dose of [14C] R406 in Healthy Male Volunteers
Phase of Trial: Phase I
Latest Information Update: 21 Aug 2012
At a glance
- Drugs Fostamatinib (Primary)
- Indications B cell lymphoma; Rheumatoid arthritis; Solid tumours
- Focus Pharmacokinetics
- 21 Aug 2012 Last checked against ClinicalTrials.gov record.
- 21 Aug 2012 Actual end date (August 2012) added as reported by ClinicalTrials.gov.
- 01 Aug 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.